2011
DOI: 10.1002/elps.201100301
|View full text |Cite
|
Sign up to set email alerts
|

Isolation of metallothionein from cells derived from aggressive form of high‐grade prostate carcinoma using paramagnetic antibody‐modified microbeads off‐line coupled with electrochemical and electrophoretic analysis

Abstract: Prostate cancer with altered zinc(II) cell metabolism is the second most frequently diagnosed cancer in developed countries. The alterations of zinc(II) metabolism can influence metabolism of other metal ions and can also be associated with the expression and translation of metal-binding proteins including metallothioneins. The aim of this article was to optimize immunoseparation protocol based on paramagnetic beads conjugated with protein G for the isolation of metallothionein. Isolated metallothionein was de… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2012
2012
2018
2018

Publication Types

Select...
8

Relationship

6
2

Authors

Journals

citations
Cited by 20 publications
(8 citation statements)
references
References 80 publications
0
8
0
Order By: Relevance
“…MT can serve as a prognostic marker in central nervous system tumors of childhood and adolescence (Rickert and Paulus, 2005;Rickert, 2004), osteosarcoma (Trieb and Kotz, 2001), breast cancer (Woolston et al, 2010;Jin et al, 2004;Gomulkiewicz et al, 2010), pancreatic islet cell tumors (Tomita, 2002), and tongue squamous-cell carcinoma (Theocharis et al, 2011). MT can also serve as a serum tumor marker in prostate cancer Masarik et al, 2011), head and neck tumors , childhood solid tumors , and melanoma . Expression of MT may help to distinguish between benign and malignant tumor, as shown in thyroid tumors (Krolicka et al, 2010), prostatic lesions (El Sharkawy et al, 2006), GI stromal tumors, and gastric carcinomas (Soo et al, 2011).…”
Section: Mts In Cancer Diagnosismentioning
confidence: 99%
“…MT can serve as a prognostic marker in central nervous system tumors of childhood and adolescence (Rickert and Paulus, 2005;Rickert, 2004), osteosarcoma (Trieb and Kotz, 2001), breast cancer (Woolston et al, 2010;Jin et al, 2004;Gomulkiewicz et al, 2010), pancreatic islet cell tumors (Tomita, 2002), and tongue squamous-cell carcinoma (Theocharis et al, 2011). MT can also serve as a serum tumor marker in prostate cancer Masarik et al, 2011), head and neck tumors , childhood solid tumors , and melanoma . Expression of MT may help to distinguish between benign and malignant tumor, as shown in thyroid tumors (Krolicka et al, 2010), prostatic lesions (El Sharkawy et al, 2006), GI stromal tumors, and gastric carcinomas (Soo et al, 2011).…”
Section: Mts In Cancer Diagnosismentioning
confidence: 99%
“…Therefore, methods of nanotechnology take advantage of nanoparticles on the basis of surface modifications possibility, which can significantly improve the quality of isolated RNA. Magnetic nanoparticles have been used for isolation and purification of nucleic acids; the use of magnetic nanoparticles provides very rapid and simple isolation of nucleic acids [449,450,451,452,453,454,455,456]. In addition, magnetic nanoparticled surface may be variously modified (these modifications include for example the introduction of silanol, epoxide, diol and carboxyl groups respectively).…”
Section: Detection Of Ppvmentioning
confidence: 99%
“…Zinc has these important roles and effects mainly as a co-factor of numerous proteins, therefore it is not surprising that metallomics and proteomics of zinc-containing proteins are emerging fields of science [6,7,8]. From these, metallothioneins are highlighted as maintainers and transporters of these proteins and their importance in zinc metabolism belongs to the interest of numerous researchers [9,10,11,12,13,14,15,16,17,18]. …”
Section: Introductionmentioning
confidence: 99%